Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under general anaesthetic
• Choline PET
• Isotope bone scan

• Treatment Facilities:
• Robot assisted laparoscopic prostatectomy
• Chemotherapy

• Support Service Facilities:
• Prostate cancer-specific CNSs
• Urology CNS
• Specialist continence services

For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021. This is the data completeness of the National Cancer Registration Dataset (NCRD). For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	293	1026
Performance Status recorded	42%	56%
PSA completed	32%	12%
Gleason Score completed	89%	86%
TNM completed	53%	63%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men with disease status determined	805	39897
Percentage of men diagnosed with metastatic disease	14%	17%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men diagnosed with low-risk localised disease	172	4684
Percentage of men with low-risk localised disease receiving radical treatment	4%	8%
No. of men diagnosed with locally advanced disease	272	15410
Percentage of men diagnosed with locally advanced disease receiving radical treatment	63%	68%

	Treatment Centre
No. of men who received radical prostatectomy (April 2022- March 2023)	172
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	13%
No. of men who received radical prostatectomy (September 2020 - August 2021)	100
Adjusted percentage of men experiencing at least one GU complication (%)	8%